Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gloria Herzog"'
Autor:
Simon Kloock, Niklas Haerting, Gloria Herzog, Marie Oertel, Niklas Geiger, Andreas Geier, Vasco Sequeira, Alexander Nickel, Michael Kohlhaas, Martin Fassnacht, Ulrich Dischinger
Publikováno v:
Nutrients, Vol 16, Iss 6, p 904 (2024)
(1) Background: Modulators of the Neuropeptide Y (NPY) system are involved in energy metabolism, but the effect of NPY receptor antagonists on metabolic-dysfunction-associated steatotic liver disease (MASLD), a common obesity-related comorbidity, are
Externí odkaz:
https://doaj.org/article/1e67dd15c82a4fa68d2d9694b48d0915
Autor:
Niklas Haerting, Gloria Herzog, Alexander Nickel, Michael Kohlhaas, Martin Fassnacht, Christian Ziegler, Ulrich Dischinger
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3109a3d778559732b48a9d1d71f2f1e7
https://doi.org/10.1530/endoabs.90.oc11.3
https://doi.org/10.1530/endoabs.90.oc11.3
Autor:
Valentin, Metzner, Gloria, Herzog, Tobias, Heckel, Thorsten, Bischler, Julia, Hasinger, Christoph, Otto, Martin, Fassnacht, Andreas, Geier, Florian, Seyfried, Ulrich, Dischinger
Publikováno v:
Journal of clinical medicine. 11(3)
Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements in phase 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5cb86dbb0ce3ffe6036763b52c2b814
https://pubmed.ncbi.nlm.nih.gov/35160204
https://pubmed.ncbi.nlm.nih.gov/35160204
Autor:
Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 753, p 753 (2022)
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 753
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 753
Background: Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92665f054a49d1fe5a044141d4e26ff2
https://doi.org/10.3390/jcm11030753
https://doi.org/10.3390/jcm11030753
Autor:
Kloock, Simon, Haerting, Niklas, Herzog, Gloria, Oertel, Marie, Geiger, Niklas, Geier, Andreas, Sequeira, Vasco, Nickel, Alexander, Kohlhaas, Michael, Fassnacht, Martin, Dischinger, Ulrich
Publikováno v:
Nutrients; Mar2024, Vol. 16 Issue 6, p904, 14p
Publikováno v:
Obesity, Fitness & Wellness Week; 4/8/2024, p2885-2885, 1p
Autor:
Metzner, Valentin1 (AUTHOR) metzner_v@ukw.de, Herzog, Gloria2 (AUTHOR) gloria.herzog@uni-wuerzburg.de, Heckel, Tobias3 (AUTHOR) heckel.t@web.de, Bischler, Thorsten3 (AUTHOR) thorsten.bischler@uni-wuerzburg.de, Hasinger, Julia1 (AUTHOR) hasinger_j@ukw.de, Otto, Christoph4 (AUTHOR) otto_c@ukw.de, Fassnacht, Martin1 (AUTHOR) fassnacht_m@ukw.de, Geier, Andreas5 (AUTHOR) geier_a2@ukw.de, Seyfried, Florian4 (AUTHOR) seyfried_f@ukw.de, Dischinger, Ulrich1 (AUTHOR) dischinger_u@ukw.de
Publikováno v:
Journal of Clinical Medicine. Feb2022, Vol. 11 Issue 3, p753. 1p.